0.8516
前日終値:
$0.857
開ける:
$0.8625
24時間の取引高:
35,876
Relative Volume:
0.03
時価総額:
$71.93M
収益:
$153.73M
当期純損益:
$-106.79M
株価収益率:
-0.4784
EPS:
-1.78
ネットキャッシュフロー:
$-115.93M
1週間 パフォーマンス:
+12.54%
1か月 パフォーマンス:
+6.62%
6か月 パフォーマンス:
-58.04%
1年 パフォーマンス:
-78.11%
Sutro Biopharma Inc Stock (STRO) Company Profile
名前
Sutro Biopharma Inc
セクター
電話
650-392-8412
住所
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
STRO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
STRO
Sutro Biopharma Inc
|
0.8516 | 63.38M | 153.73M | -106.79M | -115.93M | -1.78 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.70 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
574.75 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.02 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
573.56 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.65 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-16 | アップグレード | Piper Sandler | Neutral → Overweight |
2025-03-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2025-03-14 | ダウングレード | BofA Securities | Buy → Underperform |
2025-03-14 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
2025-03-14 | ダウングレード | Wedbush | Outperform → Neutral |
2024-05-08 | 開始されました | BofA Securities | Buy |
2023-11-09 | 開始されました | Deutsche Bank | Buy |
2023-10-06 | 開始されました | Oppenheimer | Outperform |
2023-03-21 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2022-08-18 | 再開されました | Wells Fargo | Overweight |
2021-06-18 | 開始されました | H.C. Wainwright | Buy |
2020-12-03 | 開始されました | Stifel | Buy |
2020-09-02 | 開始されました | Jefferies | Buy |
2020-07-16 | 開始されました | Wells Fargo | Overweight |
2020-01-13 | 開始されました | SunTrust | Buy |
2019-10-07 | 開始されました | BTIG Research | Buy |
2019-07-18 | 開始されました | Deutsche Bank | Buy |
2019-04-29 | 開始されました | H.C. Wainwright | Buy |
2018-10-22 | 開始されました | JMP Securities | Mkt Outperform |
2018-10-22 | 開始されました | Piper Jaffray | Overweight |
2018-10-22 | 開始されました | Wedbush | Outperform |
すべてを表示
Sutro Biopharma Inc (STRO) 最新ニュース
Here's Why Sutro Biopharma (NASDAQ:STRO) Must Use Its Cash Wisely - Yahoo Finance
What analysts say about Sutro Biopharma Inc. stockFree Stock Market Return Analysis - jammulinksnews.com
What drives Sutro Biopharma Inc. stock priceExplosive capital gains - jammulinksnews.com
Sutro Biopharma Inc. Stock Analysis and ForecastPhenomenal capital appreciation - jammulinksnews.com
Sutro Biopharma partners with FDA to develop ADC reference materials - Investing.com
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates - The Manila Times
FDA Selects Sutro Biopharma's Revolutionary Platform to Shape Future of Cancer Drug Development - Stock Titan
Is Sutro Biopharma Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
what makes sutro biopharma inc. stock price move sharplyReal Time Alert Service - Newser
Why Sutro Biopharma Inc. stock attracts strong analyst attentionHigh Return Potential - Newser
How Sutro Biopharma Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser
What makes Sutro Biopharma Inc. stock price move sharplyFree Consultation - Newser
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Vontobel Holding Ltd. Has $33,000 Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma, Inc.(NasdaqGM: STRO) dropped from Russell 2000 Dynamic Index - MarketScreener
Sutro Biopharma Faces NASDAQ Non-Compliance Notice - TipRanks
Sutro Biopharma (NASDAQ:STRO) Upgraded to Overweight at Piper Sandler - Defense World
Sutro Biopharma (STRO) Receives Upgrade to Overweight by Piper S - GuruFocus
Piper Sandler Upgrades Sutro Biopharma to Overweight From Neutral, $2 Price Target - MarketScreener
Sutro Biopharma (STRO) Receives Upgrade with Promising Drug Prospects | STRO Stock News - GuruFocus
Piper Sandler upgrades Sutro Biopharma stock rating on pipeline progress By Investing.com - Investing.com Canada
Bank of America Corp DE Sells 22,894 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Analysts - Defense World
Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight | ST - GuruFocus
Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Position Decreased by Two Sigma Investments LP - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Millennium Management LLC - Defense World
ProShare Advisors LLC Boosts Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Nuveen Asset Management LLC Acquires 124,154 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma names Greg Chow as new CFO - Investing.com
Sutro Biopharma (STRO) Appoints New CFO Greg Chow | STRO Stock N - GuruFocus
Sutro Biopharma names Greg Chow as new CFO By Investing.com - Investing.com Canada
Sutro Biopharma Appoints Greg Chow as Chief Financial Officer - The Manila Times
Sutro Biopharma Inc (STRO) 財務データ
収益
当期純利益
現金流量
EPS
Sutro Biopharma Inc (STRO) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
Borgman Anne Elizabeth | CHIEF MEDICAL OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
69,063 |
0 |
122,161 |
Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
Apr 11 '25 |
Option Exercise |
0.00 |
21,250 |
0 |
59,683 |
NEWELL WILLIAM J | CEO |
Mar 05 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
299,239 |
FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
99,027 |
ALBINI EDWARD C | CFO AND SECRETARY |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
135,675 |
FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 04 '25 |
Option Exercise |
0.00 |
9,125 |
0 |
94,025 |
NEWELL WILLIAM J | CEO |
Mar 04 '25 |
Option Exercise |
0.00 |
31,125 |
0 |
291,625 |
Chung Jane | PRESIDENT AND COO |
Mar 04 '25 |
Option Exercise |
0.00 |
7,875 |
0 |
100,642 |
大文字化:
|
ボリューム (24 時間):